Fat loss and lean mass preservation. AOD-9604 in the morning fasted for lipolysis; Ipamorelin + CJC-1295 nightly for GH-driven muscle preservation. Diet and training are critical co-factors.
The body composition stack operates on a split-timing principle. AOD-9604 (a fragment of the HGH C-terminus) is administered in the morning in a fasted state — it promotes fat cell lipolysis without the insulin-blunting effects of full GH. Ipamorelin and CJC-1295 are given together at night, producing a strong pulsatile GH release during sleep that protects and builds lean muscle mass.
This approach addresses both sides of body composition simultaneously: reducing fat tissue while preserving and building muscle — the classic recomposition goal that is notoriously difficult with diet and training alone.
This stack requires dietary discipline to work. AOD-9604's lipolytic effect is blunted by insulin — if taken after carbohydrate consumption, the effect is significantly reduced. A minimum 2-hour fast before administration is essential, ideally longer.
Protein intake must be adequate for muscle synthesis — the GH pulse at night drives protein synthesis in skeletal muscle, but only if substrate (amino acids) is available. 1.8–2.2g/kg bodyweight of protein daily is recommended alongside this protocol.
AOD-9604 typically produces noticeable fat loss in weeks 6–10 with consistent fasted administration. Ipamorelin + CJC-1295 effects on lean mass and sleep quality are usually apparent at 3–4 weeks. Full body recomposition results are typically assessed at the 12–16 week mark. Blood work at baseline, month 4 (mid-cycle), and month 10 (end of year).
Full dosing, titration schedule, blood work timing and cycling notes are available inside the platform. Use the calendar to track your protocol.